Product Description
The Infant Phototherapy Unit YR06222 is a sophisticated medical device designed to treat neonatal jaundice effectively. This state-of-the-art equipment utilizes ultraviolet light to reduce high bilirubin levels in newborns. It is engineered to provide precise and efficient phototherapy, enhancing the outcomes for infants who need immediate intervention.
The phototherapy unit features a bilirubin radiancy of 3600μw/cm2 at 4cm distance, ensuring a powerful therapeutic response. The adjustable lighting intensity options (33%, 67%, 100%) offer flexibility in treatment settings to cater to varying medical requirements. With the additional presence of white light, the unit maintains a visual check on the patient during therapy.
Designed with an optimal radiant space of 360 × 210 mm, the YR06222 ensures that the focused treatment area is adequately covered. Operating at a power capacity of ≤ 100VA, this unit is energy-efficient while providing a wavelength range of 400nm to 550nm, which is ideal for phototherapy applications. The uniformity in radiant distribution is greater than 0.4, enhancing the uniform treatment effects across the infant’s skin.
The therapy time can be precisely set from 0 to 99 hours and 59 minutes, accommodating long treatment cycles as needed. Additionally, the temperature monitor range between 30 – 40°C helps in maintaining a controlled environment around the infant, which is crucial for their comfort and safety during extended therapy sessions.
| Model | YR06222 |
| Bilirubin radiancy (4cm) | 3600μw/cm2 (60μw/cm2/nm) |
| Lighting intensity | 33%, 67%, 100% |
| White light | Yes |
| Radiant space | 360 × 210 mm |
| Power | ≤ 100VA |
| Wave length | 400nm ~ 550nm |
| Radiant uniformity | > 0.4 |
| Therapy time set | 0-99h59m |
| Temperature monitor range | 30 – 40°C |
Market Pricing
The Infant Phototherapy Unit YR06222 is competitively priced within the market for neonatal care devices. Typically, these units range from approximately 3300 USD to 4100 USD. This pricing reflects the advanced technology and reliability inherent in the YR06222 model, ensuring that healthcare providers receive excellent value for a crucial medical tool.
With its innovative features and efficient design, investing in this phototherapy unit means hospitals and clinics can provide better care for newborns suffering from jaundice. Facilities looking for cost-effective yet highly functional equipment will find the YR06222 phototherapy unit a compelling choice.
Frequently Asked Questions
What is the primary use of the Infant Phototherapy Unit YR06222?
This unit is primarily used to treat neonatal jaundice by delivering light therapy that reduces bilirubin levels in infants.
How does the adjustable lighting intensity help in treatment?
The adjustable lighting intensities (33%, 67%, 100%) allow for the personalization of treatment, accommodating the specific needs and conditions of each infant.
Is the unit safe for prolonged use?
Yes, the YR06222 is designed with safety in mind, including a temperature monitor range of 30 – 40°C and radiant uniformity > 0.4 to ensure even treatment across the infant’s skin.
Advantages and Disadvantages
Advantages:
- High efficacy with 3600μw/cm2 bilirubin radiancy.
- Adjustable intensity for tailored treatment options.
- Compact design with optimal radiant space.
- Energy-efficient operation with power ≤ 100VA.
- Wide wavelength coverage ensuring effective treatment.
Disadvantages:
- Initial investment cost may be high for smaller clinics.
- Requires trained personnel for optimal operation and handling.
Field Usage
The YR06222 phototherapy unit is extensively used in neonatal intensive care units and maternity wards to address hyperbilirubinemia in newborns. It is highly effective in reducing bilirubin levels, thus preventing serious complications such as kernicterus. The unit’s adaptable intensity settings and comprehensive wavelength range allow healthcare professionals to tailor the treatment to individual patient needs effectively.
In practice, the unit is placed over the baby’s incubator or cradle, ensuring maximum exposure to the therapeutic light. The controlled environment, along with its precision settings, ensures a reliable performance, making it a preferred choice for hospitals and clinics worldwide.
Recommendations
For those using the YR06222 phototherapy unit, it is recommended to regularly calibrate the device to maintain optimal performance and accuracy. Ensure personnel are trained and familiar with adjusting the intensity settings to match patient requirements. Regular maintenance of the unit’s components will prolong its lifespan and efficiency.
Facilities are encouraged to explore purchasing options through Kalstein’s platform, where automatic quotations can be procured for added convenience. This makes the acquisition of this cutting-edge device a streamlined process, providing benefits to both patients and healthcare providers. In addition, integrating this unit into neonatal care protocols will significantly enhance treatment outcomes for infants with jaundice.
If you are looking for a fusion of innovation and quality, you have come to the right place. At Kalstein, we offer you the luxury of exploring our exclusive catalog of laboratory equipment. We manufacture each piece of equipment with a level of excellence. Our intuitive and agile online purchasing channels are designed for your convenience, ensuring the most friendly prices. Do not hesitate any longer, we bring science to life, it is time to be part of our community. https://kalstein.net/en/product/infant-phototherapy-unit-yr06222/.
